Abstract
Soft tissue calcification occurs in many parts of the body, including the gingival tissue. Epithelial cell-derived MVs can control many functions in fibroblasts but their role in regulating mineralization has not been explored. We hypothesized that microvesicles (MVs) derived from gingival epithelial cells could regulate calcification of gingival fibroblast cultures in osteogenic environment. Human gingival fibroblasts (HGFs) were cultured in osteogenic differentiation medium with or without human gingival epithelial cell-derived MV stimulation. Mineralization of the cultures, localization of the MVs and mineral deposits in the HGF cultures were assessed. Gene expression changes associated with MV exposure were analyzed using gene expression profiling and real-time qPCR. Within a week of exposure, epithelial MVs stimulated robust mineralization of HGF cultures that was further enhanced by four weeks. The MVs taken up by the HGF's did not calcify themselves but induced intracellular accumulation of minerals. HGF gene expression profiling after short exposure to MVs demonstrated relative dominance of inflammation-related genes that showed increases in gene expression. In later cultures, OSX, BSP and MMPs were significantly upregulated by the MVs. These results suggest for the first time that epithelial cells maybe associated with the ectopic mineralization process often observed in the soft tissues.
Similar content being viewed by others
Introduction
Physiological mineralization is essential for correct development and function of hard tissues at proper sites, such as bone, teeth and growth plate1. On the other hand, mineralization also occurs in soft connective tissues, including blood vessels, skin, tendon and heart valves in pathologic conditions2,3. Ectopic calcification in the cardiovascular system or joints results in serious clinical outcomes because treatment options are limited4,5,6. In maxillofacial region, central ossifying fibroma, peripheral ossifying fibroma (POF) and calcifying fibrous pseudotumor have been reported as calcified fibrous lesions7,8,9,10,11. In addition, sporadic soft tissue calcifications have been found in computed tomography images when there were no clinical symptoms12,13. Still, the pathological mechanisms of soft tissue calcifications are not clear, although believed to be linked to environmental and clinical factors, such as aging, injury, cancer, diabetes and inflammation2,3. Several studies have shown a correlation between decreased bone mineral density and abnormal turnover and prevalence of ectopic soft tissue calcification14,15. Factors leading to pathological calcification of soft tissues however, remain elusive.
In recent years, characterization of extracellular vesicles and their biological effects have been studied in-depth for their diverse origins and release mechanisms due to their anticipated diagnostic or therapeutic value. Based on size, morphology and biological features, extracellular vesicles (EVs) are classified into exosomes, microvesicles (MVs) and apoptotic bodies16. While apoptotic bodies are only generated as a result of cell death, MVs and exosomes are continuously released by live cells. EVs are known to play an important role in mediating cell-to-cell communication via stabilization of labile factors secreted into the extracellular environment (i.e. peptides, proteins, lipids and microRNA)17, and recent studies suggest that EVs may play a role in cancer, immune regulation and human pathophysiology. EVs have also potential therapeutic value17,18,19,20,21. MVs are membrane vesicles with a diameter ranging from 100 nm to 1 µm, formed by direct outward budding of the plasma membrane. They can travel and reach distant targets in the interstitial or other body fluids while their cargo is being kept protected from degradation by the surrounding lipid membrane22.
We have reported previously that MVs released by keratinocytes regulate several genes in dermal fibroblasts via multiple intracellular signaling pathways, leading to increased cell migration and fibroblast-mediated angiogenesis in vitro23. In addition to MVs, exosomes released from oral mucosal epithelial cell sheets exhibit pro-regenerative effects on wound healing24. In general, EVs, especially from mesenchymal stem cells (MSCs), have been described to possess wound healing-supporting properties25,26,27. We have also reported that oral bacterial biofilms increase MV production in gingival epithelial cells (GECs)28. These epithelial MVs increased expression of genes associated with inflammation and matrix degradation in gingival fibroblasts28. Moreover, several studies have demonstrated MV-related vascular calcification. Mineralized vesicles were only abundant in the extracellular matrix (ECM) at sites of vascular calcification and not in healthy arteries. Another study reported that vascular smooth muscle cells (VSMCs) released EVs rich in osteogenic differentiation-related biomarkers under inflammatory condition29. EVs derived from stressed VSMCs aggregate and form microcalcification zones30. We have demonstrated previously that gingival fibroblasts are neural crest-derived cells that retain MSC-like properties and can differentiate to multiple lineages, including undergoing osteogenic differentiation, in vitro31,32,33. Since gingiva can develop various calcified lesions, we investigated whether MVs derived from gingival epithelial cells could regulate calcification of gingival fibroblast cultures in an osteogenic environment. Surprisingly, epithelial MVs promoted ectopic intracellular mineralization in gingival fibroblasts that was associated with early expression of inflammation related genes and late gene expression of some classical osteogenic differentiation markers and MMPs.
Results
Gingival epithelial cell-derived MVs induce calcification of human gingival fibroblast cultures
Calcification of HGF cultures after exposure to MVs was investigated by two methods. First, the von Kossa staining was used to identify mineralization nodules after seven and twenty-eight days of exposure. Second, the mineralization of cultures was quantified in real-time using the IncuCyte system with calcein green staining. Using von Kossa staining, first clear signs of appearance of mineralized nodules were observed in 7-days-old cultures exposed to the MVs in the OM, while no nodules were identified in the untreated controls (Fig. 1a). In 28-days-old cultures, epithelial MVs further stimulated the formation of mineralized nodules (Fig. 1a). HGFs in OM also showed some mineralization but significantly less than in cultures exposed to MVs (Fig. 1a). No deposition of mineralized nodules was detected in BM at any time point.
To quantify the mineralization in the MV-exposed cultures, calcein fluorescence was used to record real-time mineral deposition over time for up to 17 days. After 7 days, calcein fluorescence started to increase in MV-treated HGF cultures in the OM medium (Fig. 1b). Calcein fluorescence then linearly increased in the treated cultures to the end of experiment at 17 days (Fig. 1b, c). OM alone induced weak mineralization while cells in the BM did not mineralize at any time point of the experiment (Fig. 1b, c).
Analysis of the mineralized nodules
After we had established that epithelial MVs induce calcification of HGF cultures, we investigated whether this mineralization occurs in the ECM or intracellularly. In the SEM images, numerous nodules were detected, matching the shapes of the cells in the MV-treated cultures but not in the controls (Fig. 2a). This accumulation mimicked intracellular mineralization rather than extracellular accumulation. To confirm this observation, we used focused ion beam (FIB) to dissect the cultures in apico-coronal direction. The FIB confirmed that the nodules were located in the cytoplasm within vesicular structures (Fig. 2b, c). Using EDS, we determined that the Ca/P ratio of the mineralized nodules was 2.0 (Fig. 2e). Outside of the nodules, only carbon was detected (Fig. 2d).
Localization of MVs in relation to mineralized nodules in the HGFs
To find out whether the mineralization is directly initiated by the MV intake, we performed double staining of the MVs and nodules at the early stages of mineralization. After three days of exposure to the red fluorescent MVs, the MVs were clearly detected as dots and diffuse patches on the cell layer (Fig. 3). At this time point, only a few calcein-fluorescent green dots were detected scattered at the periphery of the cells and not co-localized with MVs (Fig. 3). After a 7-day treatment with MVs, the number of calcium nodules significantly increased around nuclei (Fig. 3). However, no co-location of the MVs and the mineralized nodules were detected (Fig. 3). HGFs without MVs showed no green calcein positive nodules at this time point.
Gene expression profiling
To investigate changes associated with the mineralization process induced by the epithelial MVs, we performed gene profiling of the early changes in 1- and 3-day-old cultures and analyzed the expression of osteogenic differentiation associated genes in cultures showing MV-induced mineralization on days 7 and 28. Total of 2125 and 1579 genes were differentially expressed in HGFs with fold-change ≥ 1.5 and at p < 0.05 in response to MV stimulation on days 1 and 3, respectively. The top 10 enriched gene ontology annotations of biological process (GOTERM_BP), cellular component (GOTERM_CC) and molecular function (GOTREM_MF) associated with differentially expressed genes (DEGs) are shown in Fig. 4a and b. After 1-day stimulation with the MVs, the categories related to cell proliferation, cytoplasmic components and protein binding were significantly regulated in HGFs (Fig. 4a). After 3-days of stimulation, the categories in treated cells had shifted to ECM components and organization (Fig. 4b). DEGs were further analyzed in groups related to ECM, Inflammatory response (INF) and Ossification (OSS) (Fig. 5a and b). In the ECM group, 84 and 110 genes were differentially regulated by MVs after one- and three-days stimulation, respectively (50 genes down and 34 up for one day and 85 genes down and 25 up for three days). In the INF group, 65 and 52 genes were regulated by the MVs with upwards trend in the majority of the genes (N = 41 and 28). In the OSS group, 52 and 53 genes were significantly regulated by the MVs with majority showing downregulation (37 and 43 genes) (Fig. 5a and b). When individual up-regulated genes were analyzed in the ECM, INF and OSS groups, it clearly showed the relative dominance of INF related genes (such as IL-8, CXCL1, C3, IL-6, SAA1, SAA2 and PTX3) that showed strong increases in gene expression (Tables 1 and 2). Not surprisingly, the TNF and NF-κB signaling pathways were concurrently increased (Table 3).
Long-term changes in expression of selected HGF genes by epithelial MVs were investigated by RT-qPCR. The results at day 7 showed that the relative expression MMP-3 was significantly upregulated while the expression of MMP-1 was not changed (Fig. 6a). Among osteogenic differentiation-related genes, OSX was significantly upregulated by the MVs. However, the expression of ALP and COL1 were significantly downregulated, and there was no change in RUNX-2 and SOX9 expression (Fig. 6b). After 28 days in the OM, the relative expression of MMP1 and MMP3 was significantly upregulated by epithelial MVs (Fig. 6c). Among osteogenic differentiation-related genes, expression of OSX and BSP continued to be upregulated (Fig. 6d). However, expression of ALP, RUNX-2 and COL1 was downregulated by the MVs (Fig. 6d).
Discussion
Pathologic ectopic calcification of soft tissues remains a significant clinical problem. Calcifications occur in blood vessel walls, in many connective tissues and in benign and malignant tumors. The molecular mechanisms of soft tissue calcification are relatively poorly understood. We report in this paper that epithelia-driven mechanisms, including MVs, could be involved in a potential pathway leading to calcification of soft tissues. The key observations of our study show that epithelial MVs strongly induced mineralization of HGF cultures, and this was associated with remarkable early upregulation of genes linked to inflammation and MMP activity. Furthermore, some of the genes associated with osteogenic differentiation such as OSX34 showed up-regulation with advanced mineralization that was largely contained in vesicles in the cytoplasm. Osteogenic differentiation is driven by key transcription factors RUNX-2 and OSX that shift the profile of gene expression to support matrix deposition (type I collagen expression) and mineralization mediated by ALP35. HGFs treated with GEC-MVs in osteogenic conditions showed consistent up-regulation of OSX. However, RUNX-2 was not altered at early time point and reduced in later time point which is curious given that OSX acts downstream of RUNX-236. In addition, the expression of ALP and type I collagen were both strongly downregulated by the MVs. Therefore, intracellular mineralization does not seem to follow gene expression profile associated with typical osteogenic differentiation. ALP is present in the MVs (data in file for Bi et al., 201628) and could be provided for the intracellular mineralization process.
EVs, including exosomes and MVs, are highly heterogenous group of vesicles produced by practically all cell types37. Before studies on EVs were common, vesicles associated with endochondral bone formation were identified and called matrix vesicles38,39. The size of these vesicles range between 50 and 400 nm and could, therefore, represent a mixture of exosomes and MVs40,41. MVs produced by osteogenic cells can accumulate Ca2+ and P intracellularly, and these vesicles serve as sites of mineral nucleation42. Epithelial MVs were internalized by the HGFs but did not seem to directly mineralize. We also did not observe any mineralization in HGF cultures that were exposed to epithelial MVs in the basic medium supporting the view that these MVs stimulate mineralization through an indirect process that is likely associated with their cargo and a suitable environment. We have previously analyzed the protein content of MVs derived from the same gingival epithelial cell line used in the present study28. There are over 2000 proteins present in the epithelial MVs, and it is likely that, in osteogenic environment, some could be recycled to form new vesicles that have Ca2+-binding capacity. For example, epithelial MVs contain several annexins that can bind both Ca2+ and phospholipids and can potentially act as nucleation sites for mineralization when released into the target cells. A previous study has demonstrated that EVs derived from mineralizing osteoblasts contain more annexins than from non-mineralizing osteoblasts42. The reasons why the newly formed vesicular structures that were mineralized with material having a Ca2+/P ratio close to hydroxyapatite were not released from the cells remains to be further investigated. Biogenesis and release of EVs is a complex process and involves often multiple steps and sorting machineries37 that may be deficient in HGFs, leading to trapping of the vesicles in the intracellular milieu. Mitochondrial participation in mineralization has been proposed in several studies43,44,45. We have not confirmed mitochondrial role for epithelial-driven and MV-associated intracellular mineralization of HGFs, and it warrants further studies. However, intracellular accumulation of mineral-containing vesicles has been observed in several other studies using different cell lines46,47,48.
Epithelial MVs caused a strong and early response of the expression of genes related to inflammation and matrix metalloproteinase activity. These findings support our previous findings that showed MV-induced gene expression of IL-6, IL-8, MMP-1 and MMP-3 in HGFs28. MVs from epidermal keratinocytes also stimulate the same genes in dermal fibroblasts, supporting the notion that this signaling machinery stands as universal communication mechanism between epithelial cells and fibroblasts23. Pro-inflammatory signals are likely to initiate normal bone healing and promote osteogenesis, but chronic inflammation is detrimental for bone formation49,50,51,52. Inflammation is also linked to extraosseous mineralization in pathological conditions, such as atherosclerosis, bone metastasis and others53,54. Serum amyloid A proteins 1 and 2 (SAA1/2) are released by liver in response to inflammation but also produced locally to regulate inflammatory cytokine release through activation of toll-like receptors TLR2 and TLR455,56. In mesenchymal stem cells, both autocrine and paracrine SAA1/2 stimulate inflammatory cytokine expression and enhanced mineralization57. In addition, the expression of inflammatory cytokines, such as IL-6 and IL-8, is highly elevated during osteogenic differentiation of bone marrow mesenchymal stem cells58. Interestingly, expression of both SAA1 and 2 were significantly increased in HGFs by the MVs and could, therefore, mediate strong up-regulation of cytokines such as Il-6, IL-8 and CXCL1. Another inflammation-related gene that was upregulated by MVs was PTX3 (long pentraxin 3). Intriguingly, PTX3 appears to play a role in regulation of both normal and ectopic mineralization by promoting cell differentiation and mineral crystal formation59. Particularly, calcifications in normal and cancerous tissue in the breast, in prostate cancer and in atheromas are associated with high PTX3 expression60,61,62. As expected, TNF and NF-B signaling pathways were increased in MV-treated HGFs. Interestingly, a low dose of TNF stimulation has been reported to induce persistent Wnt expression through NF-κB and JNK signaling pathways, resulting in bone formation63. Our previous studies have shown that JNK signaling pathway is activated by epithelial MVs in HGFs and dermal fibroblasts23,28. Therefore, NF-κB and JNK signaling could participate in MV-induced mineralization of HGF cultures.
In the present study, MMP1 and MMP3 were strongly upregulated by epithelial MVs, corroborating our previous observations with dermal and gingival fibroblasts23,28. Epithelial MVs regulate MMPs mainly through ERK1/2 signaling. Increased expression of MMPs, including MMP-1 has been also found in bone marrow MSCs during osteogenic differentiation64. Other MMPs, such as MMP-2, MMP-9 and MT1-MMP, are also stimulated during early mineralization64,65. MMP-1 may directly promote osteogenic differentiation through ERK and JNK pathways66. MMP-1 stimulation of bone marrow MSCs upregulated osteogenic differentiation markers (RUNX2, OSX, OPN and OCN) and promoted mineralization66. Whether other MMPs could also directly stimulate osteogenic differentiation remains unknown. Overall, a number of MMPs play a crucial role in bone development and pathology but their role is multifaceted67.
Possible limitations of the present study include the use of MVs from spontaneously immortalized human gingival epithelial cells. It is well known that the cargo in the EVs can vary depending on cell types and pathological conditions46. However, epithelial MVs from spontaneously immortalized gingival and epidermal keratinocytes as well as from primary keratinocytes similarly induce MMP and cytokine expression on fibroblasts from different origins23,28, suggesting that at least some of the cargo proteins are shared. In addition, we were not able to determine the molecules involved in the induction of the mineralization and why the minerals were retained in the cytoplasm. These interesting questions will need to be answered in a separate future study.
In conclusion, the present study shows that gingival epithelial-derived MVs induce rapid mineralization of gingival fibroblast cultures in osteogenic conditions. This process is associated with early upregulation of inflammation and MMP activity-related genes that could positively regulate the osteogenic differentiation. Remarkably, that the mineralization remained largely intracellular, warrants further investigation.
Methods
Cell culture
Spontaneously immortalized human gingival epithelial cell (GEC) line was established in the authors’ laboratory68. This cell line has partial triploid phenotype but no known mutations. Normal primary human gingival fibroblast strain (GFBL-HN; referred here as HGFs) was isolated from healthy attached gingiva of a healthy 18-year-old female69. This cell strain possesses an average phenotype of several primary gingival fibroblast strains tested in our previous study69. Both cell types were maintained in basic medium (BM) containing Dulbecco’s modified Eagle’s medium (Gibco, Life Technologies, Grand Island, NY, USA) supplemented with 23 mM sodium bicarbonate, 20 mM HEPES, 1% antibiotics (50 μg/mL of streptomycin sulfate, 100 U/mL of penicillin; Gibco), and 10% heat-inactivated fetal bovine serum (FBS; Gibco).
MV collection
MV collection was performed as previously described28. Briefly, confluent GECs were rinsed with phosphate-buffered saline (PBS) and cultured in FBS-free medium for 48 h. Conditioned medium from the cell cultures was collected and centrifuged (Sorvall RC 5B Plus, Mandel Scientific; manufactured by DuPont, Newtown, CT, USA) at 4℃, first at 3,000 g for 15 min to remove cellular debris and then at 25,000 g for 30 min to collect MVs. MV pellets were rinsed once with PBS, homogeneously re-suspended in FBS-free medium and kept at 4℃ until used. Total MV protein content was measured with Bio-Rad Protein Assay reagent (Bio-Rad Laboratories, Hercules, CA, USA) and spectrophotometry at 570 nm and used for standardizing the vesicle amounts in the experiments. Characterization of MVs (physical size, proteomics analysis) produced by the GEC line used has been published in a previous study28.
HGF stimulation by epithelial MVs in osteogenic conditions
HGFs were seeded in 24-well plates (2 × 105 cells per well) for 48 h. Then, the medium was changed to osteogenic differentiation medium [OM; BM supplemented with 50 µg/ml of ascorbic acid (Sigma-Aldrich, St Louis, MI, USA), 100 nM dexamethasone (Sigma- Aldrich), 100 nM vitamin D3 (Sigma-Aldrich), and 10 mM ß-glycerophosphate (Sigma- Aldrich)] and MVs were added to the final concentration of 30 μg protein/ml. Medium was changed and fresh MVs were added every 72 h.
Staining of mineralized nodules by von Kossa
Von Kossa staining was performed as previously reported70. In brief, the cells were fixed in 4% formaldehyde (Fisher Scientific, Fair Lawn, NJ, USA) after 7- and 28-days culture periods and incubated with 2% silver nitrate (Fisher Scientific) in dark for 10 min and then exposed to bright light for 15 min. The plates were then washed with distilled water and dehydrated in 100% ethanol. The samples were then examined by light microscopy71.
Calcification of cultures measured by IncuCyte real-time imaging
For real-time imaging of calcification, 10 mM calcein green (Sigma-Aldrich) solution, which fluoresces when bound to calcium crystals, was prepared in 0.1 M NaOH, and the solution was further diluted to 1 mM and sterile-filtered. Calcein solution was added directly to the differentiation medium in final concentration of 1 μM72. The culture medium was changed every three days. The green fluorescence mask of GCU 270 was set in order to exclude background noise to avoid artifacts72. The images were taken in real-time, using an automated Incucytetm S3 live-cell imaging system (Sartorius Corporation, Edgewood, NY, USA) at a series of time points up to 17 days.
Sample preparation for SEM
HGFs were cultured on 10 mm tissue culture plastic coverslips (Sarstedt, Newton, NC, USA) in 24-well plates for four weeks, fixed with 2.5% glutaraldehyde (EM grade, Electron Microscopy Sciences (EMS), Hatfield, PA, USA), postfixed with 1% osmium tetroxide (EMS) and dehydrated in a graded series of ethanol followed by critical point drying (Samdri-795; Tousimis Research Corporation, Rockville, MD, USA). The coverslips were mounted on stubs and coated with 20-nm carbon (Med020, Leica Microsystems Inc, Concord, ON, Canada). Cells were visualized by SEM (Helios 650 Nanolab dual beam, FEI, Hillsboro, OR, USA) using the backscattered electrons (BSE) imaging mode (atomic number contrast) and electron energy sectioning73. Once a suitable area was identified, a cross section was created with the Focused Ion Beam (FIB), exposing the interior of the cells. The BSE imaging mode was used to distinguish the cell and intracellular calcified vesicles based on atomic number contrast. To confirm the presence of Ca (L alpha of 3.9 keV) and P (K alpha 2.013) areas of high density were analyzed using EDX point analysis (Octane Pro Detector, EDAX, Mahwah, NJ, USA).
Double staining of MVs and mineral deposits
To analyze direct relationship between MVs and calcification, the GECs were labeled using Vybrant DiI cell labeling solution (1:200; Invitrogen, Eugene, OR, USA) for 1 h. Labeled MVs were collected as above. HGFs were seeded on gelatin (0.2%)-coated glass coverslips in BM. After 48 h, the medium was changed to OM supplemented with 1 μM calcein green, and Dil-labeled MVs were added. MVs were added only once at day 0. Medium was changed at day 4. At each time point, the cells were fixed with 4% formaldehyde at room temperature for 20 min and the nuclei then stained with 300 nM DAPI (Molecular Probes Inc., Eugene, OR, USA) in PBS for 15 min. Samples were mounted with Immuno-mount solution (Thermo Scientific, Pittsburgh, PA, USA) and examined using an Axioplan II Fluorescent microscope (Carl Zeiss Inc., Jena, Germany). The images were captured using Northern Eclipse software (Empix Imaging, Mississauga, ON, Canada).
Gene expression profiling
HGFs were seeded in 6-well plates (2 × 105 cells per well) in BM for 48 h, after which the medium was changed to OM and MVs were added as above. After a 1- or 3-day culture, total RNA was extracted using Purelink RNA Mini kit (Thermo Scientific) according to the manufacturer’s protocol and assessed for purity by the RNA/DNA Calculator (GeneQuant Pro; Amersham Biosciences, Little Chalfont, Buckinghamshire, UK). The quality of RNA samples was assessed using Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), and samples with RNA Integrity Number (RIN) ≥8 were used for further analysis74. Qualifying samples were then prepped following the standard protocol for the NEBnext Ultra ii Stranded mRNA (New England Biolabs, Ipswich, MA, USA). Sequencing was performed on the Illumina NextSeq 500 (Illumina Inc. San Diego, CA, USA) with Paired End 42 bp × 42 bp reads. De-multiplexed read sequences were then aligned to the reference sequence using STAR aligners (https://www.ncbi.nlm.nih.gov/pubmed/23104886). Assembly and differential expression were estimated using Cufflinks (http://cole-trapnell-lab.github.io/cufflinks/) through bioinformatics apps available on Illumina Sequence Hub. Gene abundances were normalized by calculating Fragments Per Kilobase of Exon Per Million Fragments Mapped (FPKM). Differentially expressed genes (DEGs) were identified with a Benjamini–Hochberg adjusted q-value of less than 5% and absolute fold-change of ≥ 1.5. The data were analyzed by the BaseSpace Correlation Engine (https://basespace.illumina.com, Illumina, Cupertino, CA) and The Database for Annotation, Visualization, and Integrated Discovery (DAVID) Resources 6.7 (at http://david.abcc.ncifcrf.gov/) using default setting. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was used to evaluate the function of DEGs in two groups.
Quantitative reverse transcription PCR (RT-qPCR)
RT-qPCR was performed as previously described75. Briefly, total RNA was obtained as above. Total RNA (1 μg) was reverse-transcribed with high-capacity cDNA reverse transcription kit (Applied Biosystems, Life Technologies, Grand Island, NY, USA), according to the manufacturer’s instructions, and Mastercycler Gradient 5331 Reverse-Transcriptase PCR Instrument (Eppendorf AG, Hamburg, Germany). The cDNA was diluted to a concentration at which the threshold-cycle value was well within the range of its standard curve. cDNA (5 μl) was mixed with 10 μl of 2 × iQ SYBR Green I Supermix (Bio-Rad) and 5 pmol of primers in 96-well plate wells. Asparagine-linked glycosylation 9 (ALG9) and glyceraldehyde- 3-phosphate dehydrogenase (GAPDH) were used as reference genes. Real-time qPCR amplification was performed using the CFX96 system (Bio-Rad Laboratories). The data were analyzed and are presented according to the comparative Ct method (CFX Manager Software, version 2.1; Bio-Rad Laboratories). PCR primers used are listed in the supplementary Table S1.
Statistical analysis
All data are expressed as mean ± standard error of the mean (SEM) from at least three independent experiments. Statistical analysis was performed using SPSS 24.0 software. Statistical differences were evaluated by Student’s t-test for paired comparisons or by one-way ANOVA followed by Tukey’s post hoc test for multiple comparisons. Statistical analysis for RT-qPCR data was done using log2-transformed data. P values < 0.05 were considered as statistically significant.
References
Feher, J. J. Quantitative Human Physiology: An Introduction 2nd edn. (Academic press, Cambridge, 2017).
Hu, J. J. et al. Pharmacological regulation of in situ tissue stem cells differentiation for soft tissue calcification treatment. Stem Cells 34, 1083–1096. https://doi.org/10.1002/stem.2306 (2016).
Lee, K. et al. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice. J. Immunol. 190, 1623–1630. https://doi.org/10.4049/jimmunol.1201479 (2013).
Giachelli, C. M. Ectopic calcification: Gathering hard facts about soft tissue mineralization. Am. J. Pathol. 154, 671–675. https://doi.org/10.1016/S0002-9440(10)65313-8 (1999).
Demer, L. L. & Tintut, Y. Vascular calcification: Pathobiology of a multifaceted disease. Circulation 117, 2938–2948. https://doi.org/10.1161/CIRCULATIONAHA.107.743161 (2008).
Xu, R., Hu, J., Zhou, X. & Yang, Y. Heterotopic ossification: Mechanistic insights and clinical challenges. Bone 109, 134–142. https://doi.org/10.1016/j.bone.2017.08.025 (2018).
Bell, D. M., Dekmezian, R. H., Husain, S. A. & Luna, M. A. Oral calcifying fibrous pseudotumor: Case analysis and review. Head Neck Pathol. 2, 343–347. https://doi.org/10.1007/s12105-008-0083-0 (2008).
El-Mofty, S. Psammomatoid and trabecular juvenile ossifying fibroma of the craniofacial skeleton: Two distinct clinicopathologic entities. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93, 296–304. https://doi.org/10.1067/moe.2002.121545 (2002).
Li, C., Men, Y., Gao, N. & Li, L. Calcifying fibrous pseudotumour of the tongue: report of a rare case. Br. J. Oral Maxillofac. Surg. 52, 974–976. https://doi.org/10.1016/j.bjoms.2014.08.016 (2014).
Nilesh, K., Punde, P., Patil, N. S. & Gautam, A. Central ossifying fibroma of mandible. BMJ Case Rep. https://doi.org/10.1136/bcr-2020-239286 (2020).
Slootweg, P. J., Panders, A. K., Koopmans, R. & Nikkels, P. G. Juvenile ossifying fibroma. An analysis of 33 cases with emphasis on histopathological aspects. J. Oral Pathol. Med. 23, 385–388. https://doi.org/10.1111/j.1600-0714.1994.tb00081.x (1994).
Missias, E. M. et al. Prevalence of soft tissue calcifications in the maxillofacial region detected by cone beam CT. Oral Dis. 24, 628–637. https://doi.org/10.1111/odi.12815 (2018).
Yalcin, E. D. & Ararat, E. Prevalence of soft tissue calcifications in the head and neck region: A cone-beam computed tomography study. Niger J. Clin. Pract. 23, 759–763. https://doi.org/10.4103/njcp.njcp_269_19 (2020).
Hyder, J. A., Allison, M. A., Criqui, M. H. & Wright, C. M. Association between systemic calcified atherosclerosis and bone density. Calcif. Tissue Int. 80, 301–306. https://doi.org/10.1007/s00223-007-9004-6 (2007).
Persy, V. & D’Haese, P. Vascular calcification and bone disease: the calcification paradox. Trends Mol. Med. 15, 405–416. https://doi.org/10.1016/j.molmed.2009.07.001 (2009).
Behera, J. & Tyagi, N. Exosomes: mediators of bone diseases, protection, and therapeutics potential. Oncoscience 5, 181–195. https://doi.org/10.18632/oncoscience.421 (2018).
Liu, M., Sun, Y. & Zhang, Q. Emerging role of extracellular vesicles in bone remodeling. J. Dent. Res. 97, 859–868. https://doi.org/10.1177/0022034518764411 (2018).
Chen, B., Li, Q., Zhao, B. & Wang, Y. Stem cell-derived extracellular vesicles as a novel potential therapeutic tool for tissue repair. Stem Cells Transl. Med. 6, 1753–1758. https://doi.org/10.1002/sctm.16-0477 (2017).
Maas, S. L. N., Breakefield, X. O. & Weaver, A. M. Extracellular vesicles: Unique intercellular delivery vehicles. Trends Cell Biol. 27, 172–188. https://doi.org/10.1016/j.tcb.2016.11.003 (2017).
Muhammad, S. A. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?. Neurochem. Int. 144, 104955. https://doi.org/10.1016/j.neuint.2021.104955 (2021).
Chong, S. Y. et al. Extracellular vesicles in cardiovascular diseases: Alternative biomarker sources, therapeutic agents, and drug delivery carriers. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20133272 (2019).
Li, A., Zhang, T., Zheng, M., Liu, Y. & Chen, Z. Exosomal proteins as potential markers of tumor diagnosis. J. Hematol. Oncol. 10, 175. https://doi.org/10.1186/s13045-017-0542-8 (2017).
Huang, P. et al. Keratinocyte microvesicles regulate the expression of multiple genes in dermal fibroblasts. J. Invest. Dermatol. 135, 3051–3059. https://doi.org/10.1038/jid.2015.320 (2015).
Sjöqvist, S. et al. Exosomes derived from clinical-grade oral mucosal epithelial cell sheets promote wound healing. J. Extracell. Vesicles 8, 1565264. https://doi.org/10.1080/20013078.2019.1565264 (2019).
Furuta, T. et al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl. Med. 5, 1620–1630. https://doi.org/10.5966/sctm.2015-0285 (2016).
Casado-Díaz, A., Quesada-Gómez, J. M. & Dorado, G. Extracellular vesicles derived from mesenchymal stem cells (MSC) in regenerative medicine: Applications in skin wound healing. Front. Bioeng. Biotechnol. 8, 146. https://doi.org/10.3389/fbioe.2020.00146 (2020).
Ha, D. H. et al. Mesenchymal stem/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration. Cells https://doi.org/10.3390/cells9051157 (2020).
Bi, J. et al. Epithelial microvesicles promote an inflammatory phenotype in fibroblasts. J. Dent. Res. 95, 680–688. https://doi.org/10.1177/0022034516633172 (2016).
Bakhshian Nik, A., Hutcheson, J. D. & Aikawa, E. Extracellular vesicles as mediators of cardiovascular calcification. Front. Cardiovasc. Med. 4, 78. https://doi.org/10.3389/fcvm.2017.00078 (2017).
Hutcheson, J. D. et al. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat. Mater. 15, 335–343. https://doi.org/10.1038/nmat4519 (2016).
Fournier, B. P., Larjava, H. & Häkkinen, L. Gingiva as a source of stem cells with therapeutic potential. Stem Cells Dev. 22, 3157–3177. https://doi.org/10.1089/scd.2013.0015 (2013).
Ferré, F. C. et al. Formation of cartilage and synovial tissue by human gingival stem cells. Stem Cells Dev. 23, 2895–2907. https://doi.org/10.1089/scd.2013.0547 (2014).
Häkkinen, L., Larjava, H. & Fournier, B. P. Distinct phenotype and therapeutic potential of gingival fibroblasts. Cytotherapy 16, 1171–1186. https://doi.org/10.1016/j.jcyt.2014.04.004 (2014).
Liu, Q. et al. Recent advances of osterix transcription factor in osteoblast differentiation and bone formation. Front Cell Dev. Biol. 8, 601224. https://doi.org/10.3389/fcell.2020.601224 (2020).
Pierce, J. L., Begun, D. L., Westendorf, J. J. & McGee-Lawrence, M. E. Defining osteoblast and adipocyte lineages in the bone marrow. Bone 118, 2–7. https://doi.org/10.1016/j.bone.2018.05.019 (2019).
Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29. https://doi.org/10.1016/s0092-8674(01)00622-5 (2002).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228. https://doi.org/10.1038/nrm.2017.125 (2018).
Anderson, H. C. Electron microscopic studies of induced cartilage development and calcification. J. Cell Biol. 35, 81–101. https://doi.org/10.1083/jcb.35.1.81 (1967).
Bonucci, E. Fine structure of early cartilage calcification. J. Ultrastruct. Res. 20, 33–50. https://doi.org/10.1016/s0022-5320(67)80034-0 (1967).
Shapiro, I. M., Landis, W. J. & Risbud, M. V. Matrix vesicles: Are they anchored exosomes?. Bone 79, 29–36. https://doi.org/10.1016/j.bone.2015.05.013 (2015).
Davies, O. G. et al. Osteoblast-derived vesicle protein content is temporally regulated during osteogenesis: Implications for regenerative therapies. Front. Bioeng. Biotechnol. 7, 92. https://doi.org/10.3389/fbioe.2019.00092 (2019).
Davies, O. G. et al. Annexin-enriched osteoblast-derived vesicles act as an extracellular site of mineral nucleation within developing stem cell cultures. Sci. Rep. 7, 12639. https://doi.org/10.1038/s41598-017-13027-6 (2017).
Lehninger, A. L. Mitochondria and calcium ion transport. Biochem. J. 119, 129–138. https://doi.org/10.1042/bj1190129 (1970).
Boonrungsiman, S. et al. The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc. Natl. Acad. Sci. U S A 109, 14170–14175. https://doi.org/10.1073/pnas.1208916109 (2012).
Ghadially, F. N. As you like it, Part 3: A critique and historical review of calcification as seen with the electron microscope. Ultrastruct. Pathol. 25, 243–267. https://doi.org/10.1080/019131201300343874 (2001).
Abdouh, M. et al. Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells. J. Exp. Clin. Cancer Res. 38, 257. https://doi.org/10.1186/s13046-019-1248-2 (2019).
Golub, E. E. Biomineralization and matrix vesicles in biology and pathology. Semin. Immunopathol. 33, 409–417. https://doi.org/10.1007/s00281-010-0230-z (2011).
Yajima, T., Kumegawa, M. & Hiramatsu, M. Ectopic mineralization in fibroblast cultures. Arch. Histol. Jpn. 47, 43–55. https://doi.org/10.1679/aohc.47.43 (1984).
Mo, I. F. et al. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol. 9, 52. https://doi.org/10.1186/1471-2121-9-52 (2008).
Raicevic, G. et al. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Eng. Part A 18, 1410–1418. https://doi.org/10.1089/ten.TEA.2011.0434 (2012).
Chang, J. et al. NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proc. Natl. Acad. Sci. U S A 110, 9469–9474. https://doi.org/10.1073/pnas.1300532110 (2013).
Zhao, L. et al. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells 29, 1601–1610. https://doi.org/10.1002/stem.703 (2011).
Reiss, A. B. et al. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis 278, 49–59. https://doi.org/10.1016/j.atherosclerosis.2018.08.046 (2018).
Kinder, M., Chislock, E., Bussard, K. M., Shuman, L. & Mastro, A. M. Metastatic breast cancer induces an osteoblast inflammatory response. Exp. Cell Res. 314, 173–183. https://doi.org/10.1016/j.yexcr.2007.09.021 (2008).
Cheng, N., He, R., Tian, J., Ye, P. P. & Ye, R. D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 181, 22–26. https://doi.org/10.4049/jimmunol.181.1.22 (2008).
Sandri, S. et al. Is serum amyloid A an endogenous TLR4 agonist?. J. Leukoc. Biol. 83, 1174–1180. https://doi.org/10.1189/jlb.0407203 (2008).
Ebert, R. et al. Acute phase serum amyloid A induces proinflammatory cytokines and mineralization via toll-like receptor 4 in mesenchymal stem cells. Stem Cell Res. 15, 231–239. https://doi.org/10.1016/j.scr.2015.06.008 (2015).
Zhang, W. et al. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells. Stem Cell Res. Ther. 8, 30. https://doi.org/10.1186/s13287-017-0485-6 (2017).
Tarantino, U. et al. The role of PTX3 in mineralization processes and aging-related bone diseases. Front. Immunol. 11, 622772. https://doi.org/10.3389/fimmu.2020.622772 (2020).
Scimeca, M. et al. Microcalcifications drive breast cancer occurrence and development by macrophage-mediated epithelial to mesenchymal transition. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20225633 (2019).
Scimeca, M. et al. Calcifications in prostate cancer: An active phenomenon mediated by epithelial cells with osteoblast-phenotype. Microsc. Res. Tech. 81, 745–748. https://doi.org/10.1002/jemt.23031 (2018).
Ninomiya, I., Kanazawa, M., Uemura, M. & Onodera, O. Elevated serum pentraxin 3 levels might predict the diagnosis of branch atheromatous disease at a very early stage. Eur. J. Neurol. 27, 1279–1284. https://doi.org/10.1111/ene.14249 (2020).
Li, X. et al. Inflammation intensity-dependent expression of osteoinductive wnt proteins is critical for ectopic new bone formation in ankylosing spondylitis. Arthritis Rheumatol. 70, 1056–1070. https://doi.org/10.1002/art.40468 (2018).
Filanti, C. et al. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J. Bone Miner. Res. 15, 2154–2168. https://doi.org/10.1359/jbmr.2000.15.11.2154 (2000).
Manduca, P. et al. Role of MT1-MMP in the osteogenic differentiation. Bone 44, 251–265. https://doi.org/10.1016/j.bone.2008.10.046 (2009).
Wu, Y. et al. MMP-1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via the JNK and ERK pathway. Int. J. Biochem. Cell Biol. 129, 105880. https://doi.org/10.1016/j.biocel.2020.105880 (2020).
Liang HPH, X. J., Xue M, Jackson CJ. vol. 3, 93–102 Metalloproteinases In Medicine (2016).
Mäkelä, M., Salo, T., Uitto, V. J. & Larjava, H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: Cellular origin and relationship to periodontal status. J Dent Res 73, 1397–1406. https://doi.org/10.1177/00220345940730080201 (1994).
Mah, W. et al. Human gingival fibroblasts display a non-fibrotic phenotype distinct from skin fibroblasts in three-dimensional cultures. PLoS ONE 9, e90715. https://doi.org/10.1371/journal.pone.0090715 (2014).
Calvert, J. W. et al. Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J. Biomed. Mater. Res. 52, 279–284. https://doi.org/10.1002/1097-4636(200011)52:2%3c279::aid-jbm6%3e3.0.co;2-8 (2000).
Lee, J. H., Rhie, J. W., Oh, D. Y. & Ahn, S. T. Osteogenic differentiation of human adipose tissue-derived stromal cells (hASCs) in a porous three-dimensional scaffold. Biochem. Biophys. Res. Commun. 370, 456–460. https://doi.org/10.1016/j.bbrc.2008.03.123 (2008).
Serguienko, A., Wang, M. Y. & Myklebost, O. Real-time vital mineralization detection and quantification during in vitro osteoblast differentiation. Biol. Proc. Online 20, 14. https://doi.org/10.1186/s12575-018-0079-4 (2018).
Owen, G. R., Meredith, D. O., Gwynn, I. & Richards, R. G. Simultaneously identifying S-phase labelled cells and immunogold-labelling of vinculin in focal adhesions. J. Microsc. 207, 27–36. https://doi.org/10.1046/j.1365-2818.2002.01035.x (2002).
Sheng, Q. et al. Multi-perspective quality control of Illumina RNA sequencing data analysis. Brief Funct. Genomics 16, 194–204. https://doi.org/10.1093/bfgp/elw035 (2017).
Bi, J. et al. Epidermal growth factor receptor signaling suppresses αvβ6 integrin and promotes periodontal inflammation and bone loss. J. Cell. Sci. https://doi.org/10.1242/jcs.236588 (2019).
Acknowledgements
This study was supported by a grant from Natural Sciences and Engineering Research Council of Canada Grant # AWD-003629.
Author information
Authors and Affiliations
Contributions
S.K. and J.B. are co-first authors and contributed equally to this work. H.L. devised the study. L.K., L.H., N.L. and H.L. designed the protocols. S.K. and J.B. performed staining, gene profiling and PCR study. G.O. performed SEM experiments. S.K. and J.B. analyzed the data. S.K. wrote the paper. All authors revised the manuscript. H.L. is responsible for the integrity of all data.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kobayashi, S., Bi, J., Owen, G. et al. Gingival epithelial cell-derived microvesicles activate mineralization in gingival fibroblasts. Sci Rep 12, 15779 (2022). https://doi.org/10.1038/s41598-022-19732-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-19732-1
This article is cited by
-
Microvesicle-eluting nano-engineered implants influence inflammatory response of keratinocytes
Drug Delivery and Translational Research (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.